1. Home
  2. JAGX vs SINT Comparison

JAGX vs SINT Comparison

Compare JAGX & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • SINT
  • Stock Information
  • Founded
  • JAGX 2013
  • SINT 1996
  • Country
  • JAGX United States
  • SINT United States
  • Employees
  • JAGX N/A
  • SINT N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • SINT Medical/Dental Instruments
  • Sector
  • JAGX Health Care
  • SINT Health Care
  • Exchange
  • JAGX Nasdaq
  • SINT Nasdaq
  • Market Cap
  • JAGX 7.4M
  • SINT 7.9M
  • IPO Year
  • JAGX N/A
  • SINT 2014
  • Fundamental
  • Price
  • JAGX $4.06
  • SINT $2.84
  • Analyst Decision
  • JAGX Strong Buy
  • SINT Strong Buy
  • Analyst Count
  • JAGX 1
  • SINT 1
  • Target Price
  • JAGX $60.00
  • SINT $28.00
  • AVG Volume (30 Days)
  • JAGX 108.3K
  • SINT 334.3K
  • Earning Date
  • JAGX 05-15-2025
  • SINT 05-15-2025
  • Dividend Yield
  • JAGX N/A
  • SINT N/A
  • EPS Growth
  • JAGX N/A
  • SINT N/A
  • EPS
  • JAGX N/A
  • SINT N/A
  • Revenue
  • JAGX $11,552,000.00
  • SINT $2,569,000.00
  • Revenue This Year
  • JAGX $22.41
  • SINT $3.26
  • Revenue Next Year
  • JAGX $30.00
  • SINT $21.87
  • P/E Ratio
  • JAGX N/A
  • SINT N/A
  • Revenue Growth
  • JAGX 13.93
  • SINT N/A
  • 52 Week Low
  • JAGX $3.75
  • SINT $1.71
  • 52 Week High
  • JAGX $110.75
  • SINT $8.60
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 33.50
  • SINT 52.40
  • Support Level
  • JAGX $4.27
  • SINT $2.66
  • Resistance Level
  • JAGX $4.90
  • SINT $2.92
  • Average True Range (ATR)
  • JAGX 0.49
  • SINT 0.22
  • MACD
  • JAGX -0.04
  • SINT -0.02
  • Stochastic Oscillator
  • JAGX 9.27
  • SINT 43.02

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: